期刊文献+

Viabahn覆膜支架在复杂股浅动脉闭塞性疾病中的应用 被引量:2

Application of Viabahn stent graft in complex superficial femoral artery occlusive diseases
下载PDF
导出
摘要 随着新器械、新技术不断涌现和临床医师的不懈努力,股动脉闭塞性病变的治疗方法在不断进步,并逐渐朝安全、有效和微创的方向发展。短段股动脉病变一般行经皮血管腔内血管成形术(PTA)或PTA加裸支架植入术,效果可靠。长段复杂的股浅动脉病变,传统的膝上股股转流术是公认的治疗方式。新型Viabahn覆膜支架的出现使得"腔内转流"成为了可能,它治疗复杂股浅动脉病变较传统治疗优势显著,通畅率满意,并可达到与人工血管旁路术相媲美的临床效果,本文综述了此方面的研究进展。 With the continuous development of new instruments and technologies and the unremitting efforts of clinicians,the treat-ment of occlusive diseases of femoral arteries has been progressing steadily,and has been developing toward safe, effective and mini-mally invasive approaches. For short-segment occlusion of femoral artery, percutaneous transluminal angioplasty (PTA) or PTA plus bare stent implantation is commonly performed, and has reliable effect. But for complex long occluded lesions of superficial femoral artery, the traditional femoral bypass is an accepted treatment modality. The new Viabahn covered stent graft have made"luminal bypass"become possible. Viabahn stent graft implantation is superior to traditional therapy with significant advantages, higher primary patency rate and comparable outcomes with prosthetic femoral-popliteal bypass surgery. This article reviewed the studies in this aspect.
作者 李志勇 周栋
出处 《中华老年多器官疾病杂志》 2017年第10期792-796,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 动脉硬化 动脉闭塞性疾病 Viabahn覆膜支架 arteriosclerosis arterial occlusive disease Viabahn stent graft
  • 相关文献

参考文献4

二级参考文献24

  • 1黄水传,黎思毅,张智,张远起,黄胜超,李建文,陈小东.腔内介入治疗下肢动脉硬化闭塞症的疗效观察[J].中国血管外科杂志(电子版),2012,4(3):169-171. 被引量:12
  • 2包俊敏,陈凯.股浅动脉支架成形术后再狭窄腔内治疗进展[J].中国血管外科杂志(电子版),2014,6(2):71-73. 被引量:3
  • 3谷涌泉,张建,汪忠镐,俞恒锡,李建新,李学锋,齐立行,郭连瑞,崔世军,罗涛,董宗俊.糖尿病性下肢缺血的外科治疗[J].中华糖尿病杂志(1006-6187),2004,12(5):328-331. 被引量:26
  • 4Henry M, Rath PC, Klonaris C, et al. Peripheral vascular diseases: an update on endovaseular therapy [J]. Indian Heart J, 2005, 57 (6): 747-766.
  • 5Dake MD. Abstract No. 10~ Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal artery disease~ 24- month update [J]. J Vase Interv Radiol, 2011, 22 (3): $7-$8.
  • 6McQuadeK~ Gable D, Hohman S, et al. Randomized comparison o~[ ePTFE/nitinol sell-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease I-J]. J Vase Surg, 2009, 49 (1).. 109-115.
  • 7Gorgani F, Telis A, Narakathu N, et al. Long-termoutcomes of the Viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery [J]. J Invasive Cardiol, 2013, 25 (12): 670-674.
  • 8Kazemi S, Djelmami-Hani M, Tumuluri R, et al. VIABAHN stent-grah for treatment of in-stent restenosis in femoropopliteal vascular occlusive disease, procedural outcome and one-year follow-up [J]. Am J Cardiol, 2006, 98 (2).. 236.
  • 9Saxon RR, Chervu A, Jones PA, et al. Heparin-bonded, expanded polytetrafhaoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial [J]. J Vasc Interv Radiol, 2013, 24 (2), 165-173.
  • 10Sixt S, Krankenberg H, Mohrle C, et al. Endovascular treatment for extensive aortoiliac artery reconstruction~ a single-center experience based on 1712 interventions [J]. J Endovasc Ther, 2013, 20 (1): 64-73.

共引文献47

同被引文献19

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部